Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- TSN -9.2%, CSIQ -1.9%
M&A news:
- AIXG -5.5% (CFIUS plans to recommend that the company's pending acquisition by Grand Chip Investment be prohibited)
Other news:
- ACOR -13.1% (announces that the MILESTONE clinical study did not show sufficient efficacy to support further development of dalfampridine to improve post-stroke walking difficulties)
- SAFM -5.4% (in sympathy with TSN)
- PPC -4.4% (in sympathy with TSN)
- IBN -1.5% (in tandem with Sensex, which closed -1.5% today)
Analyst comments:
- CEMP -4.1% (downgraded to Market Perform from Outperform at Cowen)
- AMFW -3% (downgraded to Underperform from Neutral at Exane BNP Paribas)
- ANF -1.7% (downgraded to Underperform at RBC Capital Mkts)
- MMM -1.2% (downgraded to Sell from Neutral at Goldman)